Medgadget

OCTOBER 31, 2023

A team at Columbia University School of Engineering and Applied Science has developed a technique to enhance chimeric antigen receptor (CAR) T cell therapy in solid tumors. The approach could enhance CAR T cell therapy in solid tumors, which hasn’t worked as well as CAR T cell therapy for blood-borne cancers to date.

Engineering 97

Engineering Patients 97

pharmaphorum

AUGUST 25, 2022

The double-headed antibody binds to CD3 on T cells and redirects them to BCMA-expressing myeloma cells, with the aim of stimulating an immune attack on the tumour, which remains incurable despite a slew of new therapies reaching the market in recent years.

FDA 90

FDA Marketing Safety Patients 90

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Oral therapy data presented at ASH. CellCentric, a U.K-based

Side effects 52

Side effects Patients Medical Medicine 52

Pharmaceutical Technology

MAY 2, 2023

IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines. Combining data from all markets, efficacy-related needs were identified as the most important unmet needs category. Cost-related unmet needs also scored highly.

Physicians 52

Physicians Marketing Patients Manufacturing 52

pharmaphorum

JULY 25, 2022

The EMA’s human medicines committee has recommended approval of Johnson & Johnson’s Tecvayli as a fourth-line therapy for multiple myeloma , joining a growing group of BCMA-targeted therapies for the blood cancer.

Medicine 52

Medicine FDA Recruitment Patients 52

European Pharmaceutical Review

AUGUST 24, 2022

An ADC combines the specificity of an antibody and the potent power of an anti?cancer 1 While the first successes underscored the potential of this class of targeted therapies, they also revealed bottle? Finding the right combination. cancer agent or disease-relevant toxin. Tubulis’ second technology platform is called Tub?tag

Engineering 81

Engineering Side effects Marketing Patients 81

PM360

OCTOBER 13, 2023

Another capability made possible by fine-tuning is the enhancement of content tagging. Content tagging has always been a labor-intensive task. Auto-tagging ensures that the right content efficiently reaches the right customers. Fine-tuning models can target domains and generate prompts to tag the content into relevant topics.

Marketing 64

Marketing Specialization Healthcare Healthcare 64